Concepedia

Roy Katso

RK

Statistics

Publications

14

Citations

1.5K

H-Index

13

Active since

1996

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

John Radcliffe Hospital

The Honourable Society of Lincoln's Inn

Ludwig Cancer Research

University of Dundee

Roy Katso is an author at GlaxoSmithKline (United Kingdom) specializing in cell signaling, signal transduction, and life sciences.

Publications per year

1996–2016

14

Publications

14

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

Laurens Kruidenier, Chun‐wa Chung, Zhongjun Cheng et al. · Nature · 2012 · 958 citations · Full text

, , +14

Phosphoinositide 3-Kinase C2β Regulates Cytoskeletal Organization and Cell Migration via Rac-dependent Mechanisms

Roy Katso, Olivier E. Pardo, Andrea Palamidessi et al. · Molecular Biology of the Cell · 2006 · 81 citations · Full text

, , +16

Functional Analysis of H-Ryk, an Atypical Member of the Receptor Tyrosine Kinase Family

Roy Katso, Robert B. Russell, Trivadi S. Ganesan · Molecular and Cellular Biology · 1999 · 77 citations

, , +17

Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one Derivatives

Susan M. Westaway, Alex Preston, Michael D. Barker et al. · Journal of Medicinal Chemistry · 2016 · 67 citations · Full text

, , +9

Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives

Susan M. Westaway, Alex Preston, Michael D. Barker et al. · Journal of Medicinal Chemistry · 2016 · 59 citations · Full text

, , +15

1–5 of 14